$33.55
Value $96M
KEQU and UNP stock compared: price, dividend, valuation and results, from SEC filings.
$33.55
Value $96M
$287.29
Value $170B
Kewaunee Scientific (KEQU) has a market value of $96M and Union Pacific (UNP) $170B. Over the last year, with dividends, KEQU moved -15.1% and UNP +32.7%. The P/E is 11.7 for KEQU and 22.4 for UNP. Dividend yield: KEQU none, UNP 1.94%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
KEQU$96M
UNP$170B
UNP is 1,770 times KEQU
Revenue, 12 months
KEQU$277M
UNP$26.4B
UNP is 95 times KEQU
Net income, 12 months
KEQU$8.2M
UNP$7.6B
UNP is 926 times KEQU
Operating margin
KEQU5.4%
UNP40.1%
34.7 points apart
ROIC
KEQU11.4%
UNP16.1%
4.7 points apart
P/E
KEQU11.7
UNP22.4
UNP is 1.9 times KEQU
Dividend yield
KEQU0.0%
UNP1.9%
1.9 points apart
5-year return
KEQU+162.3%
UNP+33.1%
129.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
KEQU+162.3%
UNP+33.1%
| Period | KEQUWith dividends | UNPWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | -15.1%Price -15.1% | +32.7%Price +29.9% |
| 3 years since November 20, 2023 | +86.3%+23.0% a yearPrice +86.3% | +38.8%+11.5% a yearPrice +29.9% |
| 5 years since November 19, 2021 | +162.3%+21.3% a yearPrice +162.3% | +33.1%+5.9% a yearPrice +19.1% |
| 10 years since November 21, 2016 | +54.0%+4.4% a yearPrice +41.6% | +254.8%+13.5% a yearPrice +185.2% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
KEQUKewaunee ScientificUNPUnion Pacific
| Price | $33.55 | $287.29 |
|---|---|---|
| Market value | $96M | $170B |
| Enterprise value (EV) | – | $199B |
| P/E | 11.7 | 22.4 |
| P/E, 5-year median | 9.9 | 20.6 |
| P/B | 1.3 | 7.7 |
| EV/EBIT | – | 18.8 |
| Free cash flow yield | 11.3% | 3.9% |
| Revenue, 12 months | $277M | $26.4B |
|---|---|---|
| Net income, 12 months | $8.2M | $7.6B |
| Free cash flow, 12 months | $11M | $6.7B |
| Earnings per share, 12 months | $2.76 | $12.83 |
| Revenue growth, year on year | 17.3% | 1.1% |
| Revenue growth a year, past | +13.8%over 5 years | +4.6%over 5 years |
| EPS growth a year, past | – | +8.7%over 5 years |
| Gross margin | 28.5% | – |
|---|---|---|
| Operating margin | 5.4% | 40.1% |
| Net margin | 3.0% | 28.9% |
| ROIC | 11.4% | 16.1% |
| ROE | 11.5% | 38.9% |
| Cash | $8.2M | $2.2B |
|---|---|---|
| Total debt | – | $31.1B |
| Net debt / EBITDA | – | 2.2 |
| Interest cover | 3.5× | 8.3× |
| Dividend yield | – | 1.9% |
|---|---|---|
| Dividend per share, 12 months | – | $5.56 |
| Dividend growth a year, past | – | +7.0%over 5 years |
| Buyback yield | – | 1.6% |
| Shareholder yield | – | 3.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Union Pacific ($170B) is about 1,770.2 times Kewaunee Scientific ($96M), at today's prices.
Since November 21, 2016, KEQU's price moved +41.6% and UNP's +185.2%. With dividends: KEQU +54.0% (+4.4% a year), UNP +254.8% (+13.5% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Kewaunee Scientific and 1.94% for Union Pacific. Over the last twelve months they paid – and $5.56 per share.
At today's price, the P/E is 11.7 for KEQU and 22.4 for UNP. The median of the last five years was 9.9 and 20.6, which shows where each stands against its own past.
Over the last twelve months, the net margin was 3.0% for Kewaunee Scientific and 28.9% for Union Pacific, and the operating margin 5.4% and 40.1%. Revenue was $277M and $26.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.